US STOCK
MOH Stock Analysis
US stocks · market data · technical indicators
Molina Healthcare, Inc.
MOHUS stocksQuote delayed 15 min
9/12 上午01:21 updated
$203.57
+3.28+1.64%
Open
$202.32
High
$204.77
Low
$199.53
Volume
14.93萬
MOH price history
-1.32%Open
205.71
Latest
202.99
High
212.43
Low
194.13
Average
201.16
Advertisement
AI Composite Technical Analysis
BetaFormula: fundamentals (40%) + technical indicators (30%) + market sentiment (30%)
AI Score65
Score range 0–100; a higher score indicates a stronger buy signal
Market Status
HoldCurrent Price$203.565
Target Price$234.1
Change %+1.64%
Institutional
Net Selling
Foreign Ownership
Flat
Market Heat
Positive
Fundamentals (US)
P/E Ratio
1,266.69x
ROE
-0.16%
P/B Ratio
2.53x
Dividend Yield
--
Market Insight
The score sits in neutral territory (65/100). Waiting for a clearer signal may be warranted. The target price implies roughly 15.00% upside.
This analysis is for reference only and does not constitute investment advice. Investing carries risk; educational content only.
Financial snapshot
MOH - Molina Healthcare, Inc.
EPS
0.16USD
Forward EPS
9.74USD
P/E
1,266.69x
Forward P/E
20.81x
P/B
2.53x
ROE
-0.16%
ROA
1.16%
Operating margin
1.40%
Profit margin
-0.02%
Revenue growth
-5.70%
Earnings growth
-75.30%
Dividend yield
--
Financial statements
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| Revenue | $10.87B | $10.80B | $11.38B | $11.48B | $11.43B |
| Gross profit | $929.00M | $1.02B | $701.00M | $927.00M | $1.17B |
| Operating income | $145.00M | $176.00M | -$162.00M | $137.00M | $373.00M |
| Net income | $60.00M | $14.00M | -$160.00M | $79.00M | $255.00M |
| Basic EPS | 1.19 | 0.27 | -3.11 | 1.51 | 4.75 |
| Diluted EPS | 1.19 | 0.27 | -3.15 | 1.51 | 4.75 |
Estimates vs actuals
Next earnings
2026-10-21
EPS estimate
0.83
Revenue estimate
$10.86B
Last surprise
+7.77%
| Date | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-10-21 | 0.83 | Not reported | — |
| 2026-07-22 | 1.40 | 1.51 | +7.77% |
| 2026-04-22 | 1.91 | 2.35 | +23.03% |
| 2026-02-05 | 0.33 | -2.75 | -921.53% |
| 2025-10-22 | 3.89 | 1.84 | -52.73% |
| 2025-07-23 | 5.53 | 5.48 | -0.89% |
| 2025-04-23 | 5.96 | 6.08 | +2.05% |
| 2025-02-05 | 5.88 | 5.05 | -14.15% |
| 2024-10-23 | 5.94 | 6.01 | +1.23% |
| 2024-07-24 | 5.60 | 5.86 | +4.67% |
| 2024-04-24 | 5.64 | 5.73 | +1.68% |
| 2024-02-07 | 4.35 | 4.38 | +0.73% |
Institutional holders
| Institution | Quarter | Value held | Portfolio weight |
|---|---|---|---|
| BlackRock Inc. | 2024-06-30 | $1.5B | 0.03% |
| VANGUARD GROUP INC | 2025-12-31 | $1.1B | 0.02% |
| STATE STREET CORP | 2026-06-30 | $401.5M | 0.01% |
| TWO SIGMA INVESTMENTS, LP | 2026-06-30 | $289.6M | 0.21% |
| RENAISSANCE TECHNOLOGIES LLC | 2026-06-30 | $72.1M | 0.10% |
| CITADEL ADVISORS LLC | 2026-06-30 | $9.8M | 0.00% |
| Bridgewater Associates, LP | 2026-06-30 | $1.9M | 0.01% |
13F quarterly filings. Reporting periods differ by institution; value and weight reflect each institution's own latest quarter.
Analyst ratings
Mean target
$209.12
Target range
$147.00 – $266.00
Implied upside
3.02%
Strong buy
1
Buy
3
Hold
14
Sell
0
Strong sell
1
Advertisement